drugset / Trial / NCT01090141
Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
Phase 4
Completed
36 enrolled
University of Texas Southwestern Medical Center
Astellas Pharma US, Inc. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the drug concentration of Micafungin amongst healthy volunteers having different weight groups.
Timeline
- Start
- 2009-11
- Primary completion
- 2010-05
- Completion
- 2010-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Micafungin | Peptide | 100 mg | Intravenous |
| Comparator | Micafungin | Peptide | 300 mg | Intravenous |